Journal of Child and Adolescent Psychopharmacology

Article	Citations
Pharmacogenetics in Child and Adolescent Psychiatry: Background and Evidence-Based Clinical Applications	24
Acknowledgment of Reviewers 2023	24
Letter to the Editor: Delayed Fibrosis and Late Course Magnetic Resonance Imaging Findings in Clozapine-Induced Myocarditis in an Adolescent	22
Rosalind Franklin Society Proudly Announces the 2022 Award Recipient for Journal of Child and Adolescent Psychopharmacology	21
Child Mind Institute Summit: Telehealth and the Coronavirus	19
Item Response Analyses of the Children's Depression Rating Scale-Revised Using Data from Clinical Studies	16
Letter to the Editor: Cannabidiol Treatment—Is There an Effect on Cognitive Functioning, Quality of Life, and Behavior? A Case Report	16
Letter to the Editor: Differences in Rate of Stimulant Medication Use for Attention-Deficit/Hyperactivity Disorder by Western and Non-Western Origins	16
From the Editor-in-Chief's Desk	15
Letter: Mirtazapine-Associated Hyperkinetic Movements in a 17-Year-Old with Autism Spectrum Disorder and Chronic Catatonia: A Case Report	14
Probing the Neurodynamic Mechanisms of Cognitive Flexibility in Depressed Individuals with Autism Spectrum Disorder	13
Comparing Symptoms of Major Depression in Youth with Confirmed Versus Suspected Bipolar Disorder	11
Methylphenidate Treatment Adherence and Persistence in Children in the Netherlands	11
The Aberrant Behavior Checklist for Fragile X Syndrome: A Qualitative Clinician Evaluation of Content Validity	11
From Consensus Statement to Pills to Pixels: New Innovations in Attention-Deficit/Hyperactivity Disorder Care	11
Efficacy of Preventing Relapse Evaluated by a Multicenter Randomized Double-Blind Placebo-Controlled Withdrawal Study of Escitalopram in Japanese Adolescents with Major Depressive Disorder	10
Program Evaluation to Aid Choice of Aripiprazole or Risperidone for Hospitalized Adolescents with Cannabis Use Disorder and Psychosis	10
Translating Attention-Deficit/Hyperactivity Disorder Rating Scale-5 and Weiss Functional Impairment Rating Scale-Parent Effectiveness Scores into Clinical Global Impressions Clinical Significance Leve	10
Description, Implementation, and Efficacy of the Comprehensive Behavioral Intervention for Tics as First-Line Treatment for Tourette and Other Tic Disorders	9
Correction to: Machine Learning Identifies Smartwatch-Based Physiological Biomarker for Predicting Disruptive Behavior in Children: A Feasibility Study, by Romanowicz et al. J Child Adolesc	9
Clonazepam Treatment of Adolescent Catatonia in A Setting of Lorazepam-Related Hypotension	9
The Occurrence of Overweight and Obesity in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder According to Three Different Diagnostic Criteria for Obesity	9
Preliminary Observations of Resting-State Magnetoencephalography in Nonmedicated Children with Obsessive-Compulsive Disorder	9
Multivariable Prediction Modeling of Antidepressant Initiation in Unipolar Depressed Adolescents: A Secondary Analysis of the IMPACT Trial	9
From the Editor-in-Chief's Desk	9

Correction to: A Multicenter Double-Blind, Placebo-Controlled Trial of Escitalopram in Children and Adolescents with Generalized Anxiety Disorder, by Strawn et al. J Child Adolesc Psychopha	8
Letter to the Editor: Skin-Testing for Clones—Pediatric Obsessive Compulsive Disorder with Misidentification Syndrome	8
Pharmacological Treatment of Tourette Disorder in Children	8
A Long-Term, Open-Label Safety and Tolerability Study of Lisdexamfetamine Dimesylate in Children Aged 4–5 Years with Attention-Deficit/Hyperactivity Disorder	8
Psychotropic Medication Prescribing for Youth at a Regional Autism Center	8
Long-Term Safety and Efficacy of Blonanserin Oral Tablet in Adolescents with Schizophrenia: A 52-Week, Multicenter, Open-Label Extension Study	7
Efficacy and Safety of Dextroamphetamine Transdermal System for the Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: Results from a Pivotal Phase 2 Study	7
Clinical Use of Clozapine Serum Level and Management of Adverse Effects in an Adolescent with Difficult to Treat Schizophrenia	7
Factors Associated with Symptom Persistence in PANS: Part II—Presenting Features, Medical Comorbidities, and IVIG Treatment History	7
Letter to the Editor: Aripiprazole-Induced Hypersexuality in an Autistic Child	7
Citalopram Did Not Significantly Improve Anxiety in Children with Autism Spectrum Disorder Undergoing Treatment for Core Symptoms: Secondary Analysis of a Trial to Reduce Repetitive Behaviors	7
Stimulant Patterns, Alone or with Other Psychotropic Classes, in Medicaid-Insured Youth Continuously Enrolled for 3–8 Years	7
Catatonic Symptoms Successfully Treated with Olanzapine in an Adolescent with Schizophrenia	7
Rosalind Franklin Society Proudly Announces the 2023 Award Recipient for Journal of Child and Adolescent Psychopharmacology	6
Neurocognitive Outcomes from Memantine: A Pilot, Double-Blind, Placebo-Controlled Trial in Children with Autism Spectrum Disorder	6
Management of COVID-19 Infection-Associated Flare in an Adolescent with Pediatric Acute Neuropsychiatric Syndrome and Obsessive-Compulsive Disorder	6
Parental Attitudes Toward Use of Ketamine in Adolescent Mood Disorders and Suicidality	6
Systematic Review and Meta-Analysis: Pharmacological and Nonpharmacological Interventions for Disruptive Mood Dysregulation Disorder	6
Investigating Predictors of Clozapine Response in Adolescents with Schizophrenia and Schizoaffective Disorder	5
Children's Relative Age and Medicine Treatment for Attention-Deficit/Hyperactivity Disorder Across Australian Jurisdictions with Different School Enrolment Policies	5
Antipsychotics in Inpatient Children and Adolescents with Seclusion and Restraint: A Preliminary Exploratory Retrospective Chart Review	5
From the Editor-in-Chief’s Desk: Gratitude for Mentors and Colleagues	5
Prevalence and Factors Affecting the Use of Antipsychotics and Antipsychotic Polypharmacy in a Child and Adolescent Psychiatry Inpatient Service	5
Monitoring of Adverse Drug Reaction-Related Parameters in Children, Youth, and Young Adults Prescribed Antipsychotic Drugs by General Practitioners	5
Serotonin Toxicity in Children and Adolescents: A Systematic Review and Meta-Analysis of Cases	5
A Short-Term Group Telehealth Cognitive Behavioral Therapy Intervention for Youth with Autism and Anxiety: A Pilot Study	5
High-Dose Benzodiazepines in Treatment of Malignant Catatonia in an Adolescent: Lorazepam, Clonazepam, and Differing Efficacy	5
Executive Functioning in Pediatric Anxiety and Its Relationship to Selective Serotonin Reuptake Inhibitor Treatment Response: A Double-Blind, Placebo-Controlled Trial	5
A Double-Blind Placebo-Controlled Pilot Study of Topiramate in Manic Adolescents Treated with Olanzapine	5
From the Editor-in-Chief's Desk	4
A Novel Cognitive Training Program Targets Stimulus-Driven Attention to Alter Symptoms, Behavior, and Neural Circuitry in Pediatric Anxiety Disorders: Pilot Clinical Trial	4
From the Editor-in-Chief's Desk	4
Acknowledgment of Reviewers 2021	4
Pediatric Psychotropic Polypharmacy: An Evaluation of the Correlates and Prevalence Across Assessment Cycles in the National Health and Nutrition Examination Survey	4
From the Editor-in-Chief’s Desk: Harnessing Pharmacoepidemiology to Provide a Brighter Future for Children with Psychiatric Disorders	4
From the Editor-in-Chief's Desk	4
Effect of a Multilayer, Extended-Release Methylphenidate Formulation (PRC-063) on Sleep in Adolescents with Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind, Fixed-Dose, Placebo-Co	4
Letter to the Editor: Liver Enzyme Elevation from Atomoxetine Use—A Case Report	4
Letter to the Editor: Edible Cannabis Use and Acute Psychotic Episode in an Adolescent	4
Incidence of Neuroleptic Malignant Syndrome During Antipsychotic Treatment in Children and Youth: A National Cohort Study	4
From the Editor-in-Chief's Desk	4
Seclusion-Induced Psychosis in an Adolescent Boy	4
Acknowledgment of Reviewers 2022	4
Adherence to Clinical Guidelines for Dose Finding and Monitoring Methylphenidate Use: A Medical Record Audit in Child and Adolescent Mental Health Care and Pediatric Settings	4
Medication Prescribing Patterns at a Youth Mental Health Service: A Single Center Retrospective Cross-sectional Study	4
Screening for Depression in Adolescents with Developmental Disabilities: Brief Report	3
From the Editor-in-Chief's Desk: Reflecting on Our Past and Future	3
A Randomized, Double-Blind, Controlled Trial of Lithium Versus Quetiapine for the Treatment of Acute Mania in Youth with Early Course Bipolar Disorder	3
Agitation Management in a 5-Year-Old Boy with X Chromosome-Linked Monoamine Oxidase-A and Monoamine Oxidase-B Deficiency	3
Clozapine and Constipation: Considerations in an Obese Adolescent Girl	3

Safety Outcomes from a Long-Term, Prospective Study of Sertraline Use in Children and Adolescents: The Sertraline Pediatric Registry for the Evaluation of Safety	3
Exploring Risk Factors for Adverse Reactions in Children with an Acute Psychotic Episode Using the Global Trigger Tool: Does Age Matter?	3
From the Editor-in-Chief's Desk: Advances in Patient-Centered Treatment for Attention-Deficit/Hyperactivity Disorder	3
An Investigation of Diversity in Childhood and Adolescent Antidepressant Studies: A Systematic Review	3
Letter to the Editor: The Impact of Adherence and CYP2C19 Phenotype on Escitalopram Exposure in Adolescents	3
A National Pediatric Telepsychiatry Curriculum for Graduate Medical Education and Continuing Medical Education	3
Low-Dose Olanzapine in the Treatment of Adolescents with Anorexia Nervosa: An Observational Naturalistic Case–Control Study	3
A Prepubertal Girl with Delusions of Pregnancy	3
From the Editor-in-Chief’s Desk: Special Issue on the Psychopharmacology of Neurodevelopmental Disorders	3
Effects of Long-Term Sertraline Use on Pediatric Growth and Development: The Sertraline Pediatric Registry for The Evaluation of Safety (SPRITES)	3
Evaluation of the Psychometric Properties of the Persian Version of Children's Depression Inventory in Iranian Adolescents	3
Differential Treatment Effects of Methylphenidate and Atomoxetine on Executive Functions in Children with Attention-Deficit/Hyperactivity Disorder	3
Neural Responses to Fluoxetine in Youths with Disruptive Behavior and Trauma Exposure: A Pilot Study	3
How Are Discrepant Parent–Child Reports Integrated? A Case of Depressed Adolescents	3
From the Editor-in-Chief's Desk	3
Navigating Pharmacological Treatment in an Adolescent with New Onset Psychosis: Clinical, Pharmacological, and Cultural Challenges	3
Letter: Exploring the Relationship Between Smartphone Addiction, Psychological Distress, Stress, and Self-Esteem Among Moroccan High School Students: A Regression Equation Modeling Study	3
From the Editor-in-Chief’s Desk: Keeping Our Eyes on The Ball and a Call for Discontinuation Research	3
Caregiver Burden, Stress, and Relationship Cohesion Among Self-Identified Caregivers of Children with Pediatric Acute-Onset Neuropsychiatric Syndrome	3
Psychotropic Polypharmacy Among Children and Youth with Autism: A Systematic Review	3
From the Editor-in-Chief’s Desk: Psychedelic Therapeutics—Something Old and Something New	3
Comparative Efficacy of Omega-3 Fatty Acid with Other Interventions for Depression in Children and Adolescents: A Systematic Review and Network Meta-Analysis	3
What Is the Added Benefit of Combining Cognitive Behavioral Therapy and Selective Serotonin Reuptake Inhibitors in Youth with Obsessive Compulsive Disorder? A Bayesian Hierarchical Modeling Meta-Analy	3
New Onset Psychosis Complicated by Akathisia and Catatonia in the Context of Recent Immigration	3
Psychopharmacological Strategies Employing Guanfacine in an Adolescent Girl with Postural Orthostatic Tachycardia Syndrome and Severe Posttraumatic Stress Disorder	3
Surface Electrocardiographic Parameters of Children and Adolescents Diagnosed with Attention-Deficit/Hyperactivity Disorder in an Ambulatory Community Pediatric Center: A Focus on Cardiac Repolarizati	2
d-Amphetamine Transdermal System in Treatment of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: Secondary Endpoint Results and Post Hoc Effect Size Analyses from a Pivo	2
A Mobile Application Adjunct to Augment Cognitive–Behavioral Group Therapy for Adolescents with Social Anxiety: Feasibility and Acceptability Results from the Wiring Adolescents with Social Anxiety vi	2
The Impact of Failed Antidepressant Trials on Outcomes in Children and Adolescents with Anxiety and Depression: A Systematic Review and Meta-Analysis	2
A Randomized, Controlled Laboratory Classroom Study of Serdexmethylphenidate and d-Methylphenidate Capsules in Children with Attention-Deficit/Hyperactivity Disorder	2
Evaluation of the Safer Use of Antipsychotics in Youth Study on Population Level Antipsychotic Initiation: An Interrupted Time Series Analysis	2
High Probability of Gene-Drug Interactions Associated with Medication Side Effects in Adolescent Depression: Results from a Randomized Controlled Trial of Pharmacogenetic Testing	2
Safety and Efficacy of Levomilnacipran Extended Release in Pediatric Patients Aged 7–17 Years with Major Depressive Disorder: Results of Two Phase 3, Randomized, Double-Blind Studies	2
Editorial to the Journal of Child and Adolescent Psychopharmacology Special Issue on Attention-Deficit/Hyperactivity Disorder Updates	2
Comparison of Fidgeting in Adolescents with Attention-Deficit/Hyperactivity Disorder Between Before and After Stimulant Medication Intake	2
Clinicians' Adherence to Guidelines When Initiating Methylphenidate Treatment	2
Rett Syndrome Behaviour Questionnaire: Variability of Scores and Related Factors	2
Long-Term Effectiveness of Off-Label Risperidone Treatment in Children and Adolescents: A Randomized, Placebo-Controlled Discontinuation Study	2
Relative Age Effect on Problematic Alcohol Use in Adolescents	2
Characteristic Similarities of Irritability Between Autism and Disruptive Mood Dysregulation Disorder	2
From the Editor-in-Chief's Desk	2
Response to Plöderl et al. re: “A Multicenter Double-Blind, Placebo-Controlled Trial of Escitalopram in Children and Adolescents with Generalized Anxiety Disorder”	2
Letter to the Editor: Transition to In-Person School After Remote Learning—Mental Health Concerns in Youth with Developmental Disabilities	2
Psychometric Properties of the PANS 31-Item Symptom Rating Scale	2
Diagnosis of Autism in School Age and Adolescence in an Ethnically Diverse Population	2
Safety and Efficacy of Brexpiprazole in the Treatment of Irritability Associated with Autism Spectrum Disorder: An 8-Week, Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial and 26-Week Open-	2
Sertraline Pediatric Registry for the Evaluation of Safety: Design and Clinical Characteristics of Pediatric Patients Prescribed Sertraline	2
Letter to the Editor: Acute Hypertriglyceridemia in an Infant Treated with Quetiapine for Pediatric Delirium	2
A Scoping Review of the Intersectionality of Autism and Intellectual and Developmental Disability with Social Inequity on Diagnosis and Treatment of Youth	2
From the Editor's Desk: Progress and Challenges for Psychiatric Phenotypes in Youth	2
Deprescribing Antidepressants in Children and Adolescents: A Systematic Review of Discontinuation Approaches, Cross-Titration, and Withdrawal Symptoms	2
Comparison of Possible Changes in Oxidative Stress, DNA Damage, and Inflammatory Markers in Children/Adolescents Diagnosed with Sluggish Cognitive Tempo and Children/Adolescents Diagnosed with Attenti	2
Correction to: The Importance of Second-Generation Antipsychotic-Related Weight Gain and Adherence Barriers in Youth with Bipolar Disorders: Patient, Parent, and Provider Perspectives, by Klein	2
Understanding and Managing New Onset Homicidal Ideation in an Adolescent with Depression	2
Short- and Long-Term Outcomes of Suboptimal Medication Adherence in Adolescents with Attention-Deficit/Hyperactivity Disorder: A Systematic Literature Review	2
Difficult-to-Treat Aggression in a Child with Autism Spectrum Disorder: Did We Miss Something? Bipolar Disorder As a Comorbid Psychiatric Condition in Autism Spectrum Disorder	2
Cost-Effectiveness and Cost Utility of Treatment of Attention-Deficit/Hyperactivity Disorder: A Systematic Review	2
Results from a Double-Blind, Randomized, Placebo-Controlled, Single-Dose, Crossover Trial of Lovastatin or Minocycline in Fragile X Syndrome	2
Trajectories and Predictors for the Development of Clinically Significant Weight Gain in Children and Adolescents Prescribed Second-Generation Antipsychotics	2
Letter to the Editor: Aripiprazole Induced Angioedema—An Unusual Cross-Reactivity Resulting in Angioedema	2
Treatment of Adolescent Depression: Comparison of Psychiatric and Pediatric Settings at an Academic Medical Center Using the VitalSign6 Application	2
Factors Affecting Delayed Initiation and Continuation of Medication Use for Attention-Deficit/Hyperactivity Disorder: A Nationwide Study	2
The Psychosocial Environment as Therapeutic Context: Family-Centered Approaches to Adolescent Psychedelic Research	2
The Mental Health Toll of the COVID-19 Pandemic on Adolescents Receiving Inpatient Psychiatric Treatment	2
From the Editor-in-Chief's Desk	1
Predictors and Moderators of Treatment Outcomes for Anxious Children Randomized to Computer-Assisted Cognitive Behavioral Therapy or Standard Community Care	1
Association Between Abnormal Metabolic Parameters and Receiving Subsequent Interventions in Children and Adolescents Initiating Second-Generation Antipsychotics	1
Pharmacological Interventions for Attention-Deficit/Hyperactivity Disorder in Children and Adolescents with Tourette Disorder: A Systematic Review and Network Meta-Analysis	1
Re: “A Multicenter Double-Blind, Placebo-Controlled Trial of Escitalopram in Children and Adolescents with Generalized Anxiety Disorder” by Strawn et al.—Concerning Harm–Benefit Ratio in a Recent Tria	1
Metabolic Monitoring for Children and Adolescents Prescribed Second-Generation Antipsychotics: A Qualitative Study with Child Psychiatrists	1
Psychopharmacological Treatment Algorithms of Manic/Mixed and Depressed Episodes in Pediatric Bipolar Disorder	1
Initiation of Aripiprazole Lauroxil Long-Acting Injectable in Adolescents During Hospitalization: A Case Series	1
Long-Acting Injectable Antipsychotic Medication Use in Youth: A Systematic Review of the Literature Along with MedWatch Safety Data and Prescriber Attitudes	1
Quality of Life and Outcomes Associated with Adverse Effects in Pediatric Patients with Attention-Deficit/Hyperactivity Disorder and Their Parents/Caregivers	1
Electronically Monitored Antidepressant Adherence in Adolescents with Anxiety Disorders: A Pilot Study	1
Not Too Rare to Matter: The Incidence of Neuroleptic Malignant Syndrome in Children and Adolescents Treated with Antipsychotics	1
A Prospective Open-Label Trial of Buspirone for the Treatment of Anxiety in Williams Syndrome	1
Efficacy, Safety, and Tolerability of Flexibly Dosed Ziprasidone in Children and Adolescents with Mania in Bipolar I Disorder: A Randomized Placebo-Controlled Replication Study	1
Biofeedback-Based Videogame May Improve Rage Attacks in Tourette Syndrome	1
Efficacy and Safety of a Long-Acting Multilayer-Release Methylphenidate Formulation (PRC-063) in the Treatment of Adolescent Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind Clinic	1

From the Editor-in-Chief's Desk	1
Polypharmacy in the Management of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: A Review and Update	1
The Effects of Methylphenidate Treatment on Bullying Perpetration and Victimization in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder	1
Topiramate for Posttraumatic Symptoms in an Obese Adolescent Girl	1
From the Editor-in-Chief's Desk	1
Letter to the Editor: Chlorpromazine-Induced Skin Pigmentation in a Pediatric Patient	1
Antipsychotics in the California Foster Care System: A 10-Year Analysis	1
Catatonia in a 16-Year-Old	1
Extension and Further Replication of the Reliability, Criterion Validity, and Treatment Sensitivity of the PANSS10 and PANSS20 for Pediatric Trials	1
Characteristics and Correlates of Metabolic Syndrome in Adolescents with Unipolar and Bipolar Depression: Results from a Cross-National Inpatient Case–Control Study	1
From the Editor-in-Chief's Desk	1
From the Editor-in-Chief's Desk	1
Use of Long-Acting Injectable Antipsychotic Medication in Youth at Winnebago Mental Health Institute: A Clinical Pathway	1
Pharmacogenetic Factors Influence Escitalopram Pharmacokinetics and Adverse Events in Youth with a Family History of Bipolar Disorder: A Preliminary Study	1
Switch to Lisdexamfetamine in the Treatment of Attention-Deficit Disorder at a Psychiatric Outpatient Clinic for School-Aged Children: A Danish Cohort Study	1
Reported Side or Adverse Effects Associated with Medication Nonadherence Among Adolescents and Young Adults with Attention-Deficit/Hyperactivity Disorder	1
From the Editor-in-Chief's Desk	1
Comorbidities in School-Age Children and Adolescents with Autism in an Ethnically Diverse Population: Brief Report	1
Impact of Pharmacogenomics on Pediatric Psychotropic Medication Prescribing in an Ambulatory Care Setting	1
Psychotropic Medication Prescribing: Youth in Foster Care Compared with Other Medicaid Enrollees	1
Improved Treatment Outcome with Haloperidol Decanoate and Amantadine in an Adolescent with Schizoaffective Disorder	1
Maternal Duplication 15q11-13 Syndrome with Autism Spectrum Disorder: Mood Stabilization by Carbamazepine	1
Clozapine for Management of Childhood and Adolescent-Onset Schizophrenia: A Systematic Review and Meta-Analysis	1
Extended-Release Lithium Sulfate in Adolescents with Bipolar Disorder: Results from a Longitudinal Prospective Cohort Study	1
Co-Occurring Anxiety in Youth with Tic Disorders: A Review	1
Sex and Aggression Characteristics in a Cohort of Patients with Pediatric Acute-Onset Neuropsychiatric Syndrome	1
Tolerability, Safety, and Effectiveness of Two Years of Treatment with Lurasidone in Children and Adolescents with Bipolar Depression	1
From the Editor-in-Chief’s Desk: Long-Acting Injectable Antipsychotics	1
A Predictive Biomarker Model Using Quantitative Electroencephalography in Adolescent Major Depressive Disorder	1
Letter to the Editor: Olanzapine Treatment and Polyuria-Polydipsia in Two Children with Autism Spectrum Disorder	1
A Randomized, Double-Blind, Placebo-Controlled, Two-Way Crossover Clinical Trial of ORADUR-Methylphenidate for Treating Children and Adolescents with Attention-Deficit/Hyperactivity Disorder	1
Influence of CYP2D6 Metabolizer Status on Risperidone and Paliperidone Tolerability in Children and Adolescents	1
Cannibalistic Ideation in a 14-Year-Old Girl: Psychosis or Trauma?	1
Electronic Health Records for Research on Attention-Deficit/Hyperactivity Disorder Pharmacotherapy: A Comprehensive Review	1
26-Week Open-Label Extension Study Evaluating the Safety and Tolerability of Flexible Doses of Oral Ziprasidone in Children and Adolescents with Bipolar I Disorder (Most Recent Episode Manic)	1
From the Editor-in-Chief's Desk	1
Efficacy and Safety of Duloxetine in Children and Adolescents with Major Depressive Disorder in Japan: A Randomized Double-Blind Placebo-Controlled Clinical Trial Followed by an Open-Label Long-Term E	1
Inflammatory Markers Profile in Older Adolescents During Treatment with Selective Serotonin Reuptake Inhibitors	1
Psychedelic Treatments in Adolescent Psychopharmacology: Considering Safety, Ethics, and Scientific Rigor	1
Prevalence and Correlates of Eating Disorder Symptoms in Adolescents with Bipolar I Disorder	1
Clozapine Treatment for Aggressive Behaviors in Youths with Neurodevelopmental Disorders	1
The Pharmacogenetic Journey in Child and Adolescent Psychopharmacology: Are We There Yet?	1
Effect of Delayed-Release and Extended-Release Methylphenidate on Caregiver Strain and Validation of Psychometric Properties of the Caregiver Strain Questionnaire: Results from a Phase 3 Trial in Chil	1
From the Editor-in-Chief's Desk	1
Letter to Editor: Measurement-Based Care in Youth—Feasibility and Acceptance	1
Letter: Integrating Insights on Ketamine Efficacy and the Risk for Polydrug Use in Adolescents with Depression	1
The Relationship Between Acute Dissociative Effects Induced by Ketamine and Treatment Response in Adolescent Patients with Treatment-Resistant Depression	1
Risk of Obesity Among Children Prescribed Atypical Antipsychotics for Six Months or More	1
Comparison of Psychiatric Readmission Rates for Child and Adolescent Patients on Long-Acting Injectable Antipsychotics Versus Oral Antipsychotics: A Mirror Study	1
Naltrexone Treatment for Multiple Substance Use Disorders in an Adolescent Boy	1
Looking for the Good Timing: Predictors of Length of Stay and Therapeutic Outcomes in Adolescent Inpatients with Severe or Treatment-Refractory Mood Disorders	1
Effectiveness of Metformin for Weight Reduction in Children and Adolescents Treated with Mixed Dopamine and Serotonin Receptor Antagonists: A Naturalistic Cohort Study	1
Reliability and Validity of the Bipolar Prodrome Symptom Interview and Scale-Full Prospective in Its Turkish Translation	1
Efficacy and Safety of Blonanserin Oral Tablet in Adolescents with Schizophrenia: A 6-Week, Randomized Placebo-Controlled Study	1
A Counting Stroop Functional Magnetic Resonance Imaging Study on the Effects of ORADUR-Methylphenidate in Drug-Naive Children with Attention-Deficit/Hyperactivity Disorder	1
Letter to the Editor: Stiffness, Parkinsonism, and Fatigue on a Case of Poor Elimination of Risperidone	1
From the Editor-in-Chief's Desk	1
Combined Topiramate and Metformin Pharmacotherapy for Second-Generation Antipsychotic-Induced Weight Gain in Pediatric Bipolar Disorder and Aggression	1
Analysis of Growth Velocity in Children with Attention-Deficit/Hyperactivity Disorder Treated for up to 12 Months with Serdexmethylphenidate/Dexmethylphenidate	1
Open-Label Dose Optimization of Methylphenidate Extended-Release Orally Disintegrating Tablet in a Laboratory Classroom Study of Children with Attention-Deficit/Hyperactivity Disorder	1
Letter to the Editor: Rapid Clozapine Concentration Increase Following Augmentation with Low-Dose Fluvoxamine in 12-Year-Old with Childhood Onset Schizophrenia	1
Treat to Sedation: Managing Intravenous Placement for Electroconvulsive Therapy in Autism with Intellectual Disability and Hyperactive Catatonia	1
Short-Term Vision-Related Ocular Side Effects of Treatment with Dexmethylphenidate for Attention-Deficit/Hyperactivity Disorder	1
Professor Alessandro Zuddas’ Impact and Legacy: The Influential Networking and Human Connection Skills of a Passionate Scientist, Clinical Academic, and Pioneer in Child and Adolescent Psychopharmacol	1
From the Editor-in-Chief's Desk	1
A Discrepancy in the Reports on Life Events Between Parents and Their Depressed Children Is Associated with Lower Responsiveness to SSRI Treatment	1
Suicide, Stimulants, and Selective Serotonin Reuptake Inhibitors: A Retrospective Chart Review	1
Myths of Randomized Controlled Trial Analysis in Pediatric Psychopharmacology	1
Letter: Paradoxical Sedation on Methylphenidate in a Child with Attention-Deficit/Hyperactivity Disorder	1